55981-09-4 | 2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$18.00	$13.00
5g	98%	in stock	$25.00	$17.00
25g	98%	in stock	$33.00	$23.00
50g	98%	in stock	$60.00	$42.00
100g	98%	in stock	$89.00	$62.00
250g	98%	in stock	$205.00	$143.00
500g	98%	in stock	$322.00	$225.00

Description

• Catalog Number: AI52552
• Chemical Name: 2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate
• CAS Number: 55981-09-4
• Molecular Formula: C12H9N3O5S
• Molecular Weight: 307.28196
• MDL Number: MFCD00416599
• SMILES: CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-]

Computed Properties

• Complexity: 428
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 21
• Hydrogen Bond Acceptor Count: 7
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 4
• XLogP3: 2

Literature

• Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs.

  Toxicological sciences : an official journal of the Society of Toxicology 20150601

• Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study.

  Environmental health perspectives 20150501

• Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.

  Antimicrobial agents and chemotherapy 20130601

• Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20121215

• Cryptosporidiosis in children following solid organ transplantation.

  The Pediatric infectious disease journal 20121101

• Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid.

  Sexual health 20120901

• Current state of Clostridium difficile treatment options.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120801

• Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model.

  The American journal of tropical medicine and hygiene 20120801

• [Treatment of refractory or recurrent Clostridium difficile infection].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20120801

• Development of metronidazole-resistant lines of Blastocystis sp.

  Parasitology research 20120701

• Validated and optimized high-performance liquid chromatographic determination of tizoxanide, the main active metabolite of nitazoxanide in human urine, plasma and breast milk.

  Journal of chromatographic science 20120701

• Cryptosporidiosis: a rare and severe infection in a pediatric renal transplant recipient.

  Pediatric transplantation 20120601

• Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands.

  Emerging infectious diseases 20120601

• Protozoan infections of the gastrointestinal tract.

  Infectious disease clinics of North America 20120601

• Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial.

  PLoS neglected tropical diseases 20120601

• Identification, characterization and cytotoxicity in vitro assay of nitazoxanide major degradation product.

  Talanta 20120515

• A new promising application for highly cytotoxic metal compounds: η6-areneruthenium(II) phosphite complexes for the treatment of alveolar echinococcosis.

  Journal of medicinal chemistry 20120510

• Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice.

  International immunopharmacology 20120501

• Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis.

  PLoS pathogens 20120501

• Tizoxanide pyridine monosolvate.

  Acta crystallographica. Section E, Structure reports online 20120501

• What would we do without metronidazole?

  The American journal of the medical sciences 20120401

• A research agenda for helminth diseases of humans: intervention for control and elimination.

  PLoS neglected tropical diseases 20120401

• Nitazoxanide for the empiric treatment of pediatric infectious diarrhea.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20120301

• The future for the treatment of genotype 4 chronic hepatitis C.

  Liver international : official journal of the International Association for the Study of the Liver 20120201

• Management of a Cryptosporidium hominis outbreak in a day-care center.

  The Pediatric infectious disease journal 20120101

• Management and outcome of cardiac and endovascular cystic echinococcosis.

  PLoS neglected tropical diseases 20120101

• WormAssay: a novel computer application for whole-plate motion-based screening of macroscopic parasites.

  PLoS neglected tropical diseases 20120101

• Effects of doxycycline on gene expression in Wolbachia and Brugia malayi adult female worms in vivo.

  Journal of biomedical science 20120101

• Virtual screening, identification and in vitro testing of novel inhibitors of O-acetyl-L-serine sulfhydrylase of Entamoeba histolytica.

  PloS one 20120101

• A data-driven predictive approach for drug delivery using machine learning techniques.

  PloS one 20120101

• Current status and future directions in the management of chronic hepatitis C.

  Virology journal 20120101

• Antiprotozoal and Antimycobacterial Activities of Pure Compounds from Aristolochia elegans Rhizomes.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study.

  Gastroenterology research and practice 20120101

• Challenges in the Management of HIV-Infected Malnourished Children in Sub-Saharan Africa.

  AIDS research and treatment 20120101

• Cholangiocarcinoma complicating secondary sclerosing cholangitis from cryptosporidiosis in an adult patient with CD40 ligand deficiency: case report and review of the literature.

  International archives of allergy and immunology 20120101

• Intestinal cryptosporidiosis in a 2-month-old child.

  The National medical journal of India 20120101

• Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland.

  Gastroenterology research and practice 20120101

• A case of Cryptosporidium infection in a child of celiac disease.

  Journal of postgraduate medicine 20120101

• Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication.

  Journal of medicinal chemistry 20111222

• Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model.

  The Journal of parasitology 20111201

• No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy.

  Antiviral research 20111201

• Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges.

  The Indian journal of medical research 20111201

• Prevalence of intestinal parasites in bakery workers in khorramabad, lorestan iran.

  Iranian journal of parasitology 20111201

• Efficacy of ginkgolic acids against Cryptosporidium andersoni in cell culture.

  Parasitology research 20111101

• Norovirus gastroenteritis successfully treated with nitazoxanide.

  The Journal of infection 20111101

• Exploration of novel in vitro assays to study drugs against Trichuris spp.

  Journal of microbiological methods 20111101

• A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori.

  The American journal of gastroenterology 20111101

• Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen.

  The American journal of gastroenterology 20111101

• Treatment and prevention of cryptosporidiosis: what options are there for a country like Zambia?

  Parasitology 20111001

• Antiviral activity of substituted salicylanilides--a review.

  Mini reviews in medicinal chemistry 20111001

• Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide.

  Experimental parasitology 20111001

• Nausea, vomiting, and diarrhea in a 9-year-old girl.

  Pediatric emergency care 20111001

• Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.

  Bioorganic & medicinal chemistry letters 20110915

• Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

  The Cochrane database of systematic reviews 20110907

• Novel and promising compounds to treat Cryptosporidium parvum infections.

  Parasitology research 20110901

• Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.

  Antiviral research 20110901

• Structure of triosephosphate isomerase from Cryptosporidium parvum.

  Acta crystallographica. Section F, Structural biology and crystallization communications 20110901

• Intervention to prevent intestinal parasitic reinfections among Tarahumara indigenous schoolchildren in northern Mexico.

  Revista panamericana de salud publica = Pan American journal of public health 20110901

• In vitro effects of some herbs used in Egyptian traditional medicine on viability of protoscolices of hydatid cysts.

  The Korean journal of parasitology 20110901

• A controlled study of nitazoxanide (NTZ) 3 years after treatment of hepatitis C genotype 4.

  Journal of the Egyptian Society of Parasitology 20110801

• Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20110701

• Cystic echinococcosis: chronic, complex, and still neglected.

  PLoS neglected tropical diseases 20110701

• Cases of cryptosporidiosis co-infections in AIDS patients: a correlation between clinical presentation and GP60 subgenotype lineages from aged formalin-fixed stool samples.

  Annals of tropical medicine and parasitology 20110701

• Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication.

  Journal of medicinal chemistry 20110623

• [Chronic C hepatitis genotype 4].

  Medicina clinica 20110611

• Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: a prospective single centre study.

  Bone marrow transplantation 20110601

• Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.

  The Journal of antimicrobial chemotherapy 20110601

• Potential drug development candidates for human soil-transmitted helminthiases.

  PLoS neglected tropical diseases 20110601

• Best strategies in recurrent or persistent Clostridium difficile infection.

  Surgical infections 20110601

• Synthesis of benzologues of Nitazoxanide and Tizoxanide: a comparative study of their in vitro broad-spectrum antiprotozoal activity.

  Bioorganic & medicinal chemistry letters 20110515

• Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs.

  The Journal of antimicrobial chemotherapy 20110501

• Tissue and stage-specific distribution of Wolbachia in Brugia malayi.

  PLoS neglected tropical diseases 20110501

• [Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug].

  Nihon rinsho. Japanese journal of clinical medicine 20110501

• Efficacy of antiamebic drugs in a mouse model.

  The American journal of tropical medicine and hygiene 20110405

• Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: identification of selective and broad spectrum activity.

  ChemMedChem 20110207

• Evaluation of nitazoxanide for the treatment of disseminated cystic echinococcosis: report of five cases and literature review.

  The American journal of tropical medicine and hygiene 20110204

• Big changes are coming in hepatitis C.

  Current gastroenterology reports 20110201

• Nitazoxanide in the treatment of chronic cutaneous leishmaniasis resistant to traditional sodium stibogluconate.

  Journal of the American Academy of Dermatology 20110101

• [Rotavirus infections].

  Medizinische Monatsschrift fur Pharmazeuten 20110101

• Amoebic dysentery.

  BMJ clinical evidence 20110101

• A comparison of the Giardia lamblia trophozoite and cyst transcriptome using microarrays.

  BMC microbiology 20110101

• Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases.

  BMC infectious diseases 20110101

• Human fascioliasis in Argentina: retrospective overview, critical analysis and baseline for future research.

  Parasites & vectors 20110101

• Chemical and physicochemical pretreatment of lignocellulosic biomass: a review.

  Enzyme research 20110101

• Antiviral drugs against hepatitis C virus.

  Genetic vaccines and therapy 20110101

• Multiple Intestinal Erosions as a Result of Hemorrhage due to Parasites: Case Reports and Review of the Literature.

  Diagnostic and therapeutic endoscopy 20110101

• Comparative drug susceptibility study of five clonal strains of Trichomonas vaginalis in vitro.

  Asian Pacific journal of tropical medicine 20110101

• The prevalence of canine Leishmania infantum infection in Sichuan Province, southwestern China detected by real time PCR.

  Parasites & vectors 20110101

• Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.

  Gastroenterology research and practice 20110101

• The Cryptosporidium parvum kinome.

  BMC genomics 20110101

• Probiotics for the control of parasites: an overview.

  Journal of parasitology research 20110101

• Prevalence and risk factors of helminths and intestinal protozoa infections among children from primary schools in western Tajikistan.

  Parasites & vectors 20110101

• Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal.

  HIV/AIDS (Auckland, N.Z.) 20110101

• Simultaneous spectrophotometric estimation of nitazoxanide and ofloxacin in tablets.

  Indian journal of pharmaceutical sciences 20110101

• RP-HPLC Method for Simultaneous Estimation of Nitazoxanide and Ofloxacin in Tablets.

  Indian journal of pharmaceutical sciences 20110101

• Mebendazole compared with secnidazole in the treatment of adult giardiasis: a randomised, no-inferiority, open clinical trial.

  Journal of parasitology research 20110101

• Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.

  BMJ case reports 20110101

• Simultaneous voltammetric determination of nitazoxanide and ofloxacin in pharmaceutical formulation.

  Indian journal of pharmaceutical sciences 20110101

• Nitazoxanide use in rota viral diarrhea. Cure or controversy?

  Indian journal of pediatrics 20101201

• Alternative therapies for Clostridium difficile infections.

  Pharmacotherapy 20101201

• Treatment of cryptosporidiosis: do we know what we think we know?

  Current opinion in infectious diseases 20101001

• New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile.

  Expert opinion on therapeutic patents 20101001

• Ascaris lumbricoides: an overview of therapeutic targets.

  Infectious disorders drug targets 20101001

• Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

  Parasitology research 20100901

• New treatments for chronic hepatitis C.

  The Korean journal of hepatology 20100901

• Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide.

  Journal of clinical gastroenterology 20100801

• Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives.

  Infectious disorders drug targets 20100801

• Helicobacter pylori treatment in the era of increasing antibiotic resistance.

  Gut 20100801

• A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.

  PLoS neglected tropical diseases 20100801

• In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani.

  Parasitology research 20100701

• Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review.

  Tropical medicine & international health : TM & IH 20100701

• Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol.

  Pediatrics 20100701

• Short course combination therapy for giardiasis after nitroimidazole failure.

  The American journal of tropical medicine and hygiene 20100701

• The enterotoxicity of Clostridium difficile toxins.

  Toxins 20100701

• Biological activity of modified and exchanged 2-amino-5-nitrothiazole amide analogues of nitazoxanide.

  Bioorganic & medicinal chemistry letters 20100615

• Antiviral treatment of chronic hepatitis B virus (HBV) infections.

  Viruses 20100601

• Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance.

  Expert review of anti-infective therapy 20100501

• A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis.

  PLoS neglected tropical diseases 20100501

• Biliary fascioliasis mimicking sphincter of Oddi dysfunction.

  Southern medical journal 20100401

• The pharmacokinetics of nitazoxanide active metabolite (tizoxanide) in goats and its protein binding ability in vitro.

  Journal of veterinary pharmacology and therapeutics 20100401

• Antiviral therapy for hepatitis C virus: beyond the standard of care.

  Viruses 20100401

• Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum.

  Antimicrobial agents and chemotherapy 20100301

• Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes.

  The Journal of antimicrobial chemotherapy 20100301

• Bacillus thuringiensis Cry5B protein is highly efficacious as a single-dose therapy against an intestinal roundworm infection in mice.

  PLoS neglected tropical diseases 20100301

• Eosinophilia secondary to strongyloides in Rhode Island.

  Medicine and health, Rhode Island 20100301

• [Antiviral therapy for chronic hepatitis C: current status and perspectives].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20100201

• Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.

  PLoS neglected tropical diseases 20100201

• Cryptosporidium and Giardia: treatment options and prospects for new drugs.

  Experimental parasitology 20100101

• The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.

  Journal of biomedicine & biotechnology 20100101

• Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective.

  Clinical and molecular allergy : CMA 20100101

• Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.

  BMC neurology 20100101

• [Nitazoxanide ('Alinia')--a promising antiparasitic drug].

  Wiadomosci parazytologiczne 20100101

• The tropical brown alga Lobophora variegata: a source of antiprotozoal compounds.

  Marine drugs 20100101

• Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines.

  Biologics : targets & therapy 20100101

• Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children.

  BMC infectious diseases 20100101

• In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide.

  Veterinary medicine international 20100101

• Childhood cryptosporidiosis: a case report.

  Journal of parasitology research 20100101

• Parasites in Mexican patients with irritable bowel syndrome: a case-control study.

  Parasites & vectors 20100101

• Diffuse small bowel thickening in AIDS patient--a case report.

  BMC infectious diseases 20100101

• Obstetrician-gynecologists and perinatal infections: a review of studies of the Collaborative Ambulatory Research Network (2005-2009).

  Infectious diseases in obstetrics and gynecology 20100101

• Hepatitis C and kidney disease.

  Hepatitis research and treatment 20100101

• In vitro Effects of Albendazole on Raillietina echinobothrida, the Cestode of Chicken, Gallus domesticus.

  Journal of young pharmacists : JYP 20100101

• New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents.

  Infection and drug resistance 20100101

• Clostridium difficile: controversies and approaches to management.

  Current opinion in infectious diseases 20091201

• Stable expression of Escherichia coli beta-glucuronidase A (GusA) in Giardia lamblia: application to high-throughput drug susceptibility testing.

  The Journal of antimicrobial chemotherapy 20091201

• Treatment of chronic hepatitis C.

  Minerva medica 20091201

• Cryptosporidiosis from a community swimming pool: outbreak investigation and follow-up study.

  Epidemiology and infection 20091101

• The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation.

  Gastroenterology 20091101

• Cryptosporidiosis in paediatric renal transplantation.

  Pediatric nephrology (Berlin, Germany) 20091101

• Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.

  The Journal of biological chemistry 20091023

• Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance.

  Journal of medicinal chemistry 20091008

• Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital.

  Pharmacy world & science : PWS 20091001

• LC: analysis of photodegradation kinetics of nitazoxanide in pharmaceutical formulations.

  Journal of chromatographic science 20091001

• An atlas of the thioredoxin fold class reveals the complexity of function-enabling adaptations.

  PLoS computational biology 20091001

• Bone hydatid disease refractory to nitazoxanide treatment.

  The American journal of tropical medicine and hygiene 20090901

• Hepatitis C virus infection and immunomodulatory therapies.

  Clinics in liver disease 20090801

• Targeting host factors: a novel rationale for the management of hepatitis C virus.

  World journal of gastroenterology 20090728

• Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20090701

• Nitazoxanide and probiotics for the treatment of recurrent Clostridium difficile infection in a peritoneal dialysis patient.

  Southern medical journal 20090701

• Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.

  PLoS neglected tropical diseases 20090701

• Sensitive high performance liquid chromatographic assay for nitazoxanide metabolite in plasma.

  Die Pharmazie 20090701

• Pelvic bone and hip joint hydatid disease revealing a retroperitoneal location.

  Orthopedic reviews 20090630

• In vitro efficacy of nitro- and halogeno-thiazolide/thiadiazolide derivatives against Sarcocystis neurona.

  Veterinary parasitology 20090610

• Nitazoxanide, tizoxanide and a new analogue [4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide; NTB] inhibit the growth of kinetoplastid parasites (Trypanosoma cruzi and Leishmania mexicana) in vitro.

  The Journal of antimicrobial chemotherapy 20090601

• Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.

  The Journal of infection 20090601

• Thiazolides: a new class of antiviral drugs.

  Expert opinion on drug metabolism & toxicology 20090601

• Thymidine kinase and uridine-cytidine kinase from Entamoeba histolytica: cloning, characterization, and search for specific inhibitors.

  Parasitology 20090501

• Effects of nitazoxanide on pharmacokinetics and pharmacodynamics of a single dose of warfarin.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090501

• Treatment of cryptosporidiosis.

  Expert review of anti-infective therapy 20090501

• Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides.

  World journal of gastroenterology 20090421

• Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.

  Journal of dairy science 20090401

• Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.

  Veterinary parasitology 20090309

• Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.

  Gastroenterology 20090301

• Nitazoxanide: beyond parasites toward a novel agent for hepatitis C.

  Gastroenterology 20090301

• Limitations of amphotericin B and nitazoxanide in the treatment of alveolar echinococcosis.

  Annals of tropical medicine and parasitology 20090301

• Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep.

  The American journal of tropical medicine and hygiene 20090301

• Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090215

• Case report: nitazoxanide for treatment of refractory bony hydatid disease.

  The American journal of tropical medicine and hygiene 20090201

• Pharmacotherapy of helminth infection.

  Expert opinion on pharmacotherapy 20090201

• Human cryptosporidiosis: a review.

  East African medical journal 20090201

• Brugia malayi: Effects of nitazoxanide and tizoxanide on adult worms and microfilariae of filarial nematodes.

  Experimental parasitology 20090101

• New antimicrobial agents for patients with Clostridium difficile infections.

  Current infectious disease reports 20090101

• Antimicrobial drugs for persistent diarrhoea of unknown or non-specific cause in children under six in low and middle income countries: systematic review of randomized controlled trials.

  BMC infectious diseases 20090101

• Current and future treatment options for HCV.

  Annals of hepatology 20090101

• Nitazoxanide for the treatment of chronic hepatitis C new opportunities but new challenges?

  Annals of hepatology 20090101

• Functional expression of a DNA-topoisomerase IB from Cryptosporidium parvum.

  Journal of biomedicine & biotechnology 20090101

• Opportunistic infections (non-cytomegalovirus) in live related renal transplant recipients.

  Indian journal of urology : IJU : journal of the Urological Society of India 20090101

• Current trends in the treatment of hepatic encephalopathy.

  Therapeutics and clinical risk management 20090101

• The old and new therapeutic approaches to the treatment of giardiasis: where are we?

  Biologics : targets & therapy 20090101

• Distribution of Brugia malayi larvae and DNA in vector and non-vector mosquitoes: implications for molecular diagnostics.

  Parasites & vectors 20090101

• High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial.

  BMC infectious diseases 20090101

• Functional proteomics of failed filtering blebs.

  Molecular vision 20090101

• Proliferative sparganosis in a dog.

  Journal of the American Veterinary Medical Association 20081201

• Liquid chromatography-tandem mass spectrometry analysis of nitazoxanide and its major metabolites in goat.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081115

• Nitazoxanide treatment of Cryptosporidium parvum in human immunodeficiency virus-infected children.

  The Pediatric infectious disease journal 20081101

• Nitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children.

  The Pediatric infectious disease journal 20081101

• Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C.

  Future microbiology 20081001

• New advances in the treatment of Clostridium difficile infection (CDI).

  Therapeutics and clinical risk management 20081001

• Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.

  Alimentary pharmacology & therapeutics 20080901

• Drug treatment and novel drug target against Cryptosporidium.

  Parasite (Paris, France) 20080901

• Nitazoxanide for cryptosporidial infection in Crohn's disease.

  Gut 20080801

• Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole.

  The Journal of antimicrobial chemotherapy 20080701

• Rapid determination of nitazoxanide in tablets using reversed-phase ultra-performance liquid chromatography (UPLC) and high-performance liquid chromatography.

  Die Pharmazie 20080701

• [New antiparasitic drugs].

  La Revue de medecine interne 20080601

• Neglected infections of poverty in the United States of America.

  PLoS neglected tropical diseases 20080601

• Nitazoxanide to treat persistent Clostridium difficile colitis.

  Current infectious disease reports 20080501

• The ancillary-care obligations of medical researchers working in developing countries.

  PLoS medicine 20080501

• Current and future treatment modalities for Clostridium difficile-associated disease.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080415

• The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide.

  Annals of tropical medicine and parasitology 20080401

• Modelling geographic variation in the cost-effectiveness of control policies for infectious vector diseases: the example of Chagas disease.

  Journal of health economics 20080301

• Preliminary evidence of nitazoxanide activity on Toxocara canis in a mouse model.

  International journal of antimicrobial agents 20080201

• Treatment of Clostridium difficile infection.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080115

• Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides.

  Experimental parasitology 20080101

• Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.

  Antiviral research 20080101

• Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infection with nitazoxanide.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20080101

• Bench-to-bedside review: Clostridium difficile colitis.

  Critical care (London, England) 20080101

• [Evaluation of the effect of nitazoxanide compared with placebo in patients with flatulence at the ambulatory consultation of the Central Clinic of Inppares-Lima].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20080101

• Developing novel anthelmintics from plant cysteine proteinases.

  Parasites & vectors 20080101

• Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection.

  Parasites & vectors 20080101

• Ability of online drug databases to assist in clinical decision-making with infectious disease therapies.

  BMC infectious diseases 20080101

• Cytokine activation is predictive of mortality in Zambian patients with AIDS-related diarrhoea.

  BMC infectious diseases 20080101

• Simultaneous RPHPLC Determination of Nitazoxanide and Ofloxacin in Combined Tablet Dosage Form.

  Indian journal of pharmaceutical sciences 20080101

• Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates.

  Parasitology research 20071201

• Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent.

  Future microbiology 20071201

• Treatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature.

  PLoS neglected tropical diseases 20071201

• Immunochemotherapy for cryptosporidiosis in immunosuppressed mouse model.

  Journal of the Egyptian Society of Parasitology 20071201

• Human intestinal parasites.

  Journal of health, population, and nutrition 20071201

• [Attention-getting zoonoses: Cryptosporidiosis].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20071110

• Failure of nitazoxanide to cure trichomoniasis in three women.

  Sexually transmitted diseases 20071001

• Clostridium difficile: new therapeutic options.

  Current opinion in pharmacology 20071001

• Nitazoxanide in the treatment of amoebiasis.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20071001

• Nitazoxanide in the treatment of Ascaris lumbricoides in a rural zone of Colima, Mexico.

  Journal of helminthology 20070901

• Treatment strategies for C. difficile associated diarrhea.

  Acta gastroenterologica Latinoamericana 20070901

• Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs.

  International journal for parasitology 20070801

• Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole.

  The Journal of antimicrobial chemotherapy 20070801

• Antimicrobial resistance and the management of anaerobic infections.

  Expert review of anti-infective therapy 20070801

• Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

  The Cochrane database of systematic reviews 20070718

• In vitro efficacy of nitro- and bromo-thiazolyl-salicylamide compounds (thiazolides) against Besnoitia besnoiti infection in Vero cells.

  Parasitology 20070701

• Clostridium difficile: recent epidemiologic findings and advances in therapy.

  Pharmacotherapy 20070701

• Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.

  The Journal of the Oklahoma State Medical Association 20070701

• Isolated gastric cryptosporidiosis in an immunocompetent patient.

  Digestive diseases and sciences 20070501

• Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis.

  British journal of clinical pharmacology 20070401

• Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.

  The Journal of antimicrobial chemotherapy 20070401

• Is nitazoxanide an effective treatment for patients with acquired immune deficiency syndrome-related cryptosporidiosis?

  Nature clinical practice. Gastroenterology & hepatology 20070301

• Hymenolepis nana infection: symptoms and response to nitazoxanide in field conditions.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20070201

• Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts.

  The Journal of antimicrobial chemotherapy 20070201

• Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum.

  International journal for parasitology 20070201

• Efficacy of nitazoxanide for cyclosporiasis in patients with sulfa allergy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070201

• Severe cryptosporidiosis in a seven-year-old renal transplant recipient: case report and review of the literature.

  Pediatric transplantation 20070201

• Nitazoxanide or CD3+/CD4+ lymphocytes for recovery from severe Cryptosporidium infection after allogeneic bone marrow transplant?

  Pediatric transplantation 20070201

• [New drugs against parasitic diseases].

  La Revue du praticien 20070131

• Prevention and treatment of cryptosporidiosis in immunocompromised patients.

  The Cochrane database of systematic reviews 20070124

• Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070101

• Survey of obstetrician-gynecologists about giardiasis.

  Infectious diseases in obstetrics and gynecology 20070101

• Nitazoxanide: a review of its use in the treatment of gastrointestinal infections.

  Drugs 20070101

• Bioequivalence study of a fixed dose combination of nitazoxanide and ofloxacin in Indian healthy volunteers.

  Arzneimittel-Forschung 20070101

• Emerging therapies in the treatment of Clostridium difficile-associated disease.

  The Annals of pharmacotherapy 20061201

• Past, present, and future therapies for Clostridium difficile-associated disease.

  The Annals of pharmacotherapy 20061201

• Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial.

  Alimentary pharmacology & therapeutics 20061115

• Antimicrobial therapy of Clostridium difficile-associated diarrhea.

  The Medical clinics of North America 20061101

• Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients.

  Alimentary pharmacology & therapeutics 20060901

• Nitazoxanide for the treatment of Clostridium difficile colitis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060815

• Treatment options for the eradication of intestinal protozoa.

  Nature clinical practice. Gastroenterology & hepatology 20060801

• Current status of anti-diarrheal and anti-secretory drugs in the management of acute childhood diarrhea.

  Indian journal of pediatrics 20060801

• [Therapeutic alternatives in case of failure of first-line treatment of intestinal helminthiasis in adults].

  Medecine tropicale : revue du Corps de sante colonial 20060801

• [Development of novel antihelminthic therapies].

  Medecine tropicale : revue du Corps de sante colonial 20060801

• Nitazoxanide for rotavirus diarrhoea?

  Lancet (London, England) 20060708

• Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial.

  Lancet (London, England) 20060708

• An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease.

  Gastroenterology clinics of North America 20060601

• Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections.

  Expert opinion on pharmacotherapy 20060501

• Practical considerations of new drugs: new choices for old problems.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060401

• Use of nitazoxanide for gastrointestinal tract infections: treatment of protozoan parasitic infection and beyond.

  Current infectious disease reports 20060301

• Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060301

• Identification of isoflavone derivatives as effective anticryptosporidial agents in vitro and in vivo.

  Journal of medicinal chemistry 20060223

• Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model.

  The Journal of antimicrobial chemotherapy 20060201

• Molecular survival strategies of Echinococcus multilocularis in the murine host.

  Parasitology international 20060101

• 14-3-3- and II/3-10-gene expression as molecular markers to address viability and growth activity of Echinococcus multilocularis metacestodes.

  Parasitology 20060101

• Nitazoxanide.

  Indian pediatrics 20051101

• Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051001

• Nitazoxanide for treatment of intestinal parasites in children.

  The Pediatric infectious disease journal 20050701

• Use of nitazoxanide as a new therapeutic option for persistent diarrhea: a pediatric perspective.

  Current medical research and opinion 20050701

• Treatment of cryptosporidiosis in immunocompromised hosts.

  Chemotherapy 20050701

• Nitazoxanide: a new thiazolide antiparasitic agent.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050415

• Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized-controlled trial.

  Alimentary pharmacology & therapeutics 20050315

• Present and future control of cryptosporidiosis in humans and animals.

  Expert review of vaccines 20041201

• New drugs and treatment for cryptosporidiosis.

  Current opinion in infectious diseases 20041201

• Parasitic infections.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20041101

• Cryptosporidiosis in children.

  Seminars in pediatric infectious diseases 20041001

• In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes.

  The Journal of antimicrobial chemotherapy 20040901

• [New drugs for the treatment of human parasitic protozoa].

  Parassitologia 20040601

• Nitazoxanide treatment for giardiasis and cryptosporidiosis in children.

  The Annals of pharmacotherapy 20040401

• Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity.

  International journal for parasitology 20040401

• New drugs 04, part 1.

  Nursing 20040201

• Nitazoxanide: a new broad spectrum antiparasitic agent.

  Expert review of anti-infective therapy 20040201

• New drugs of 2003.

  Journal of the American Pharmacists Association : JAPhA 20040101

• [Nitazoxanide vs albendazole against intestinal parasites in a single dose and for three days].

  Salud publica de Mexico 20040101

• In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar.

  Annals of clinical microbiology and antimicrobials 20040101

• [Nitazoxanide: adverse effects].

  Salud publica de Mexico 20040101

• Evaluation of the in vitro effect of albendazole, metronidazole and nitazoxanide on viability and structure of Giardia lamblia cysts.

  Journal of submicroscopic cytology and pathology 20040101

• Efficacy of antigiardial drugs.

  Expert opinion on drug safety 20031101

• Human studies provide insight into the pathogenesis, immunology, and treatment of cryptosporidiosis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031001

• Giardia intestinalis.

  Current opinion in infectious diseases 20031001

• Nematocidal activity of nitazoxanide in laboratory models.

  Parasitology research 20031001

• Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.

  Cell research 20030801

• Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.

  Journal of the Egyptian Society of Parasitology 20030801

• A review of chemotherapeutic approaches to the treatment of cryptosporidiosis.

  Expert review of anti-infective therapy 20030801

• Nitroheterocyclic drugs with broad spectrum activity.

  Parasitology research 20030601

• Nitazoxanide (Alinia)--a new anti-protozoal agent.

  The Medical letter on drugs and therapeutics 20030414

• Nitazoxanide: an important advance in anti-parasitic therapy.

  The American journal of tropical medicine and hygiene 20030401

• Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico.

  The American journal of tropical medicine and hygiene 20030401

• Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model.

  Folia parasitologica 20030301

• [New drugs for treatment of parasitic infections].

  Casopis lekaru ceskych 20030301

• Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru.

  Alimentary pharmacology & therapeutics 20030101

• [International therapeutics].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20030101

• New drug for parasitic infections in children.

  FDA consumer 20030101

• [Blastocystosis: nitazoxanide as a new therapeutic option].

  Revista da Sociedade Brasileira de Medicina Tropical 20030101

• Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.

  Lancet (London, England) 20021102

• In-vitro transfer of nitazoxanide across the intestinal epithelial barrier.

  The Journal of pharmacy and pharmacology 20021001

• Cryptosporidiosis.

  Current opinion in infectious diseases 20021001

• Nitazoxanide as a broad-spectrum antiparasitic agent.

  The Journal of infectious diseases 20020601

• Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses.

  International journal of clinical pharmacology and therapeutics 20020501

• Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d.

  International journal of clinical pharmacology and therapeutics 20020501

• Treatment of intestinal parasitic infections: a review of nitazoxanide.

  Trends in parasitology 20020301

• Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children.

  The American journal of tropical medicine and hygiene 20020301

• In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.

  The Journal of antimicrobial chemotherapy 20020101

• Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru.

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20020101

• In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.

  The Journal of eukaryotic microbiology 20020101

• Experimental infection of cats with Tritrichomonas foetus.

  American journal of veterinary research 20011101

• Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru.

  Alimentary pharmacology & therapeutics 20010901

• Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide.

  The Journal of infectious diseases 20010801

• Case report: Nitazoxanide treatment failure in chronic isosporiasis.

  The American journal of tropical medicine and hygiene 20010801

• Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.

  The Journal of infectious diseases 20010701

• Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010615

• [In vitro measurement of nitazoxanide sensitivity of 4 Giardia duodenalis isolates obtained from different hosts].

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20010101

• Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells.

  The Journal of antimicrobial chemotherapy 20000701

• Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.

  The Journal of antimicrobial chemotherapy 20000401

• Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.

  Antimicrobial agents and chemotherapy 19981101

• Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.

  Antimicrobial agents and chemotherapy 19980801

• Screening of compounds for antimicrosporidial activity in vitro.

  Folia parasitologica 19980101